Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,737 | 189 | 99.6% |
| Education | $13.89 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,213 | 75 | $0 (2024) |
| Novo Nordisk Inc | $639.90 | 35 | $0 (2024) |
| ABBVIE INC. | $404.93 | 17 | $0 (2024) |
| PFIZER INC. | $263.35 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $206.68 | 11 | $0 (2024) |
| Boston Scientific Corporation | $149.42 | 1 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $136.10 | 8 | $0 (2024) |
| Allergan Inc. | $128.74 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $99.97 | 5 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $80.42 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $583.86 | 26 | ABBVIE INC. ($83.58) |
| 2023 | $924.79 | 46 | ABBVIE INC. ($321.35) |
| 2022 | $458.45 | 19 | Boston Scientific Corporation ($149.42) |
| 2021 | $211.50 | 8 | Lilly USA, LLC ($85.38) |
| 2020 | $143.34 | 8 | Lilly USA, LLC ($75.68) |
| 2019 | $422.89 | 26 | Lilly USA, LLC ($209.05) |
| 2018 | $650.98 | 38 | Novo Nordisk Inc ($276.48) |
| 2017 | $355.55 | 19 | Lilly USA, LLC ($138.34) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $35.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $35.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: VACCINES | ||||||
| 07/31/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Oncology | ||||||
| 06/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Oncology | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: VACCINES | ||||||
| 02/27/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: VACCINES | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: VACCINES | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,290 | 3,183 | $188,787 | $146,947 |
| 2022 | 31 | 2,250 | 2,955 | $192,895 | $87,261 |
| 2021 | 31 | 2,217 | 2,927 | $189,591 | $147,929 |
| 2020 | 38 | 2,457 | 3,348 | $180,305 | $138,641 |
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 487 | $68,167 | $46,625 | 68.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 225 | 225 | $31,865 | $31,021 | 97.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 236 | 434 | $43,093 | $27,719 | 64.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $5,900 | $5,619 | 95.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 44 | $3,230 | $3,165 | 98.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 19 | $3,689 | $2,744 | 74.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 86 | $2,585 | $2,532 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 206 | 357 | $2,605 | $2,524 | 96.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 25 | 26 | $2,491 | $2,441 | 98.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 182 | 228 | $2,483 | $2,360 | 95.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,517 | $2,297 | 91.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 145 | 163 | $2,231 | $2,139 | 95.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $2,240 | $2,025 | 90.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 189 | 255 | $2,042 | $1,941 | 95.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 174 | 186 | $3,133 | $1,925 | 61.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 27 | 29 | $1,488 | $1,458 | 98.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 65 | 74 | $1,243 | $1,218 | 98.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 15 | 15 | $1,339 | $1,155 | 86.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 66 | 105 | $1,020 | $999.60 | 98.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 21 | 21 | $621.60 | $609.21 | 98.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 32 | 32 | $666.61 | $605.44 | 90.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 52 | 71 | $629.60 | $588.59 | 93.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 13 | $740.35 | $580.45 | 78.4% |
| 86618 | Analysis for antibody borrelia burgdorferi (lyme disease bacteria) | Office | 2023 | 17 | 33 | $561.99 | $550.77 | 98.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 31 | 31 | $482.21 | $458.18 | 95.0% |
About Dr. Anthony Martini, MD
Dr. Anthony Martini, MD is a Internal Medicine healthcare provider based in Warwick, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912986456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Martini, MD has received a total of $3,751 in payments from pharmaceutical and medical device companies, with $583.86 received in 2024. These payments were reported across 190 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,737).
As a Medicare-enrolled provider, Martini has provided services to 9,214 Medicare beneficiaries, totaling 12,413 services with total Medicare billing of $520,777. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Warwick, NY
- Active Since 01/12/2006
- Last Updated 02/25/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912986456
Products in Payments
- TRULICITY (Drug) $819.88
- VRAYLAR (Drug) $336.50
- Ozempic (Drug) $315.31
- MOUNJARO (Drug) $286.20
- UBRELVY (Drug) $178.79
- PREVNAR 20 (Biological) $173.07
- General - Pain Management (Device) $149.42
- Saxenda (Drug) $143.33
- SPIRIVA RESPIMAT (Drug) $106.87
- SHINGRIX (Biological) $85.96
- KEVEYIS (Drug) $82.39
- GORE CARDIOFORM Septal Occluder (Device) $80.42
- STIOLTO (Drug) $71.98
- JARDIANCE (Drug) $70.46
- Rybelsus (Drug) $65.52
- Impella (Device) $59.27
- GVOKE PFS (Drug) $53.71
- XARELTO (Drug) $48.31
- Cologuard Collection Kit (Device) $44.90
- CAPLYTA (Drug) $40.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Warwick
Dr. Arnav Kumar, Md, MD
Internal Medicine — Payments: $31,845
Shuangping Wang, M.d, M.D
Internal Medicine — Payments: $12,925
Munawar Azam, Md, MD
Internal Medicine — Payments: $9,846
Dr. Vikram Malik, Md, MD
Internal Medicine — Payments: $9,694
Matthew Ethier, Md, MD
Internal Medicine — Payments: $6,800
Kimberly Humulock, Do, DO
Internal Medicine — Payments: $3,874